相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1045.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥352.0 |
| 规格: | 5 mg | 产品价格: | ¥950.0 |
| 规格: | 10 mg | 产品价格: | ¥1500.0 |
| 规格: | 25 mg | 产品价格: | ¥2600.0 |
| 规格: | 50 mg | 产品价格: | ¥3900.0 |
| 规格: | 100 mg | 产品价格: | ¥5850.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
BLU9931
CAS No. : 1538604-68-0
MCE 国际站:BLU9931
产品活性:BLU9931 是一种有效的,高度选择性的,不可逆的成纤维细胞生长因子受体 4 (FGFR4) 抑制剂,其 IC50 值为 3 nM,Kd 值为 6 nM。BLU9931 具有显着的抗肿瘤活性。
研究领域:Protein Tyrosine Kinase/RTK
作用靶点:FGFR
In Vitro: BLU9931 inhibits proliferation of HCC cell lines that express an intact FGFR4 signaling complex, with EC50s of 0.07 μM, 0.11 μM and 0.02 μM for Hep 3B, HuH7 and JHH7 cells, respectively.
BLU9931 (0.3-300 nM; 1 hour; MDA-MB-453 and Hep 3B cells) treatment demonstrates potent, dose-dependent reduction of phosphorylation of FGFR4 signaling pathway components, including fibroblast growth factor receptor substrate 2 (FRS2), MAPK, and AKT in MDA-MB-453 cells. BLU9931 shows dose-dependent inhibition of the signaling cascade downstream of FGFR4. BLU9931 exhibits potent inhibition of phosphorylation of the FGFR4 pathway components in Hep 3B cells. BLU9931 treatment leads to induction of caspase-3/7 activity, indicative of induction of apoptosis that results in inhibition of signaling downstream of FGFR4.
BLU9931 (100 nM; 0 -24 hours; Hep 3B cells) treatment increases CYP7A1 mRNA expression and the expression of the proliferative marker EGR1 is inhibited.
In Vivo: BLU9931 (10-100 mg/kg; oral administration; twice every day; for 21 days; mice) treatment demonstrates antitumor activity in HCC xenograft models.
相关产品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Covalent Screening Library | Reprogramming Compound Library | Chemical Probe Library | Anti-Lung Cancer Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | Lenvatinib | Regorafenib | Nintedanib | Ponatinib | Erdafitinib | Infigratinib | Pemigatinib | Pazopanib | Futibatinib | Fexagratinib | PD173074 | Heparan Sulfate | Formononetin | SU 5402 | Masitinib | Dovitinib | KW-2449 | Ferulic acid | Fisogatinib | Roblitinib | Gandotinib | Triamcinolone acetonide | LY2874455 | PD-166866 | Sulfatinib | SM1-71 | Rogaratinib
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验tkwggxOgYxdvEj687uNt8dWwWVYV2b9dxboxU7Fq4EyUvr4G9XJG91xREJIPdrhkmwVKsiD4/XSDp68KjDu1R+Ni2pIRqoJmwcMwgQxBgIWPDLGNvAgmkFEIqCJf7Z7oU6g4+pq3RmGhUTDoipkLb+JCH1vseeSNeg2yp8pis7RYj3MWtSCZocj84Lx/KNpMm4KJparjSP9CkkYkVSbGgzKBdEggFQ9M0yEtnjITYAIpTEADRbpMwcyJbUMFj7+jaeiZIDcC4P71
技术资料暂无技术资料 索取技术资料
















